natgillin/translations-raw huggingface dataset:
Common (may affect up to 1 in 10 people) - light-headedness or fainting due to low blood pressure, high blood pressure - worsening of Parkinson`s symptoms, dizziness, drowsiness - vomiting, abdominal pain and discomfort, heartburn, dry mouth, constipation - inability to sleep, hallucinations, confusion, abnormal dreams (including nightmares), tiredness - mental changes - including problems with memory, anxiety and depression (possibly with thoughts of suicide) - heart or artery disease events (e.g. chest pain), irregular heart rate or rhythm - more frequent falling - shortness of breath - increased sweating, rashes - muscle cramps, swelling of legs - blurred vision - anaemia - decreased appetite, decreased weight - headache, joint pain - urinary tract infection
Pogosti neželeni učinki (lahko se pojavijo pri največ 1 od 10 bolnikov): - vrtoglavica ali omedlevica zaradi nizkega krvnega tlaka, visok krvni tlak - poslabšanje simptomov Parkinsonove bolezni, omotičnost, zaspanost - bruhanje, bolečine in nelagodje v trebuhu, zgaga, suha usta, zaprtje - nespečnost, halucinacije, zmedenost, nenormalne sanje (vključno z nočnimi morami), utrujenost - duševne motnje - vključno s težavami s pomnjenjem, anksioznostjo in depresijo (lahko s samomorilnimi mislimi) - dogodki, povezani z boleznijo srca ali arterij (npr. bolečina v prsih), neenakomeren srčni utrip ali ritem - pogosto padanje - zasoplost - močnejše potenje, izpuščaj - mišični krči, oteklost nog - zamegljen vid - anemija - zmanjšanje apetita, zmanjšanje telesne mase - glavobol, bolečine sklepov - okužbe sečil
General characteristics of the active substances
Glavne značilnosti učinkovin
Levodopa/Carbidopa/Entacapone Orion comes in six different pack sizes (10, 30, 100, 130, 175 or 250 tablets).
Zdravilo Levodopa/Carbidopa/Entacapone Orion je na razpolago v šestih različnih velikostih pakiranja (10, 30, 100, 130, 175 ali 250 tablet).
10 film-coated tablets 30 film-coated tablets 100 film-coated tablets 130 film-coated tablets 175 film-coated tablets 250 film-coated tablets
10 filmsko obloženih tablet 30 filmsko obloženih tablet 100 filmsko obloženih tablet 130 filmsko obloženih tablet 175 filmsko obloženih tablet 250 filmsko obloženih tablet
In such patients it is advisable to introduce entacapone treatment as a separate treatment (entacapone tablets) and adjust the levodopa dose if necessary, before switching to Levodopa/Carbidopa/Entacapone Orion.
Pri takih bolnikih je priporočljivo pred prehodom na zdravilo Levodopa/Carbidopa/Entacapone Orion uvesti zdravljenje z entakaponom kot samostojnim zdravljenjem (entakapon v obliki tablet), odmerek levodope pa po potrebi prilagoditi.
If this happens, your doctor may need to change the dose of your antiparkinson medicine - experience diarrhoea: monitoring of your weight is recommended in order to avoid potentially excessive weight loss - experience progressive anorexia, asthenia (weakness, exhaustion) and weight decrease within a relatively short period of time.
Če se to zgodi, se morate posvetovati s svojim zdravnikom, ker je morda pri vas treba spremeniti odmerek antiparkinsonskih zdravil; - dobite drisko: se priporoča nadziranje telesne mase, da preprečite morebitno preveliko izgubo telesne mase; - pojavi progresivna anoreksija, astenija (slabost, izčrpanost) in zmanjšanje telesne mase v relativno kratkem časovnem obdobju, je treba pomisliti na splošni zdravstveni pregled, vključno z ocenitvijo delovanja jeter; - začutite, da bi morali prenehati jemati zdravilo Levodopa/Carbidopa/Entacapone Orion, glejte poglavje »Če ste prenehali jemati zdravilo Levodopa/Carbidopa/Entacapone Orion«
What you need to know before you take Levodopa/Carbidopa/Entacapone Orion
Kaj morate vedeti, preden boste vzeli zdravilo Levodopa/Carbidopa/Entacapone Orion
When more levodopa is required, an increase in the frequency of doses and/or the use of an alternative strength of Levodopa/Carbidopa/Entacapone Orion should be considered, within the dose recommendations.
Kadar je potreben večji odmerek levodope, se je treba odločiti za pogostejše odmerjanje in/ali uporabiti zdravilo Levodopa/Carbidopa/Entacapone Orion drugačne (večje) jakosti, seveda v mejah priporočenega odmerjanja.
10 film-coated tablets 30 film-coated tablets 100 film-coated tablets 130 film-coated tablets 175 film-coated tablets
10 filmsko obloženih tablet 30 filmsko obloženih tablet 100 filmsko obloženih tablet 130 filmsko obloženih tablet 175 filmsko obloženih tablet
Patients and carers should be made aware that behavioural symptoms of impulse control disorders including pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists and/or other dopaminergic treatments containing levodopa including Levodopa/Carbidopa/Entacapone Orion.
Bolnike in njihove skrbnike je treba opozoriti, da pri bolnikih, ki se zdravijo z agonisti dopamina in/ali drugimi dopaminergičnimi zdravljenji, ki vsebujejo levodopo, vključno z zdravilom Levodopa/Carbidopa/Entacapone Orion, lahko pride do vedenjskih simptomov, ki so znak motenj pri obvladovanju impulzov, kar vključuje patološko hazardiranje, povečan libido,
Film-coating of 50/12.5/200 mg, 100/25/200 mg and 150/37.5/200 mg: Glycerol (85 per cent) (E422)
Filmska obloga pri 50/12,5/200 mg, 100/25/200 mg in 150/37,5/200 mg: glicerol (85 odstotkov) (E422) hipromeloza (E464) magnezijev stearat polisorbat 80 (E433)
Do not take Levodopa/Carbidopa/Entacapone Orion if you:
Ne jemljite zdravila Levodopa/Carbidopa/Entacapone Orion:
Cardiac disorders Common:
Srčne bolezni Pogosti:
Other medicines and Levodopa/Carbidopa/Entacapone Orion
Druga zdravila in zdravilo Levodopa/Carbidopa/Entacapone Orion
- Rhabdomyolysis secondary to severe dyskinesias or neuroleptic malignant syndrome (NMS) has been observed rarely in patients with Parkinson's disease.
- Pri bolnikih s Parkinsonovo boleznijo redko opažajo pojav rabdomiolize, ki bi bila posledica hude diskinezije ali malignega nevroleptičnega sindroma (NMS).
Label 10 tablets 30 tablets 100 tablets 130 tablets 175 tablets
Nalepka 10 tablet 30 tablet 100 tablet 130 tablet 175 tablet
125 mg/31.25 mg/200 mg Light brownish red, oval film-coated tablets marked with ‘LCE 125' on one side.
125 mg/31,25 mg/200 mg Svetlorjavkasto rdeče ovalne filmsko obložene tablete z oznako »LCE 125« na eni strani.
Brownish or greyish red, elongated-ellipse shaped, unscored film-coated tablets marked with ‘LCE 150' on one side.
Rjavkaste ali sivkasto-rdeče podolgovate filmsko obložene tablete v obliki elipse brez zareze z oznako »LCE 150« na eni strani.
maprotiline, venlafaxine and paroxetine - rimiterole and isoprenaline, used to treat respiratory diseases - adrenaline, used for severe allergic reactions - noradrenaline, dopamine and dobutamine, used to treat heart diseases and low blood pressure - alpha-methyldopa, used to treat high blood pressure - apomorphine, which is used to treat Parkinson's disease.
Ta vključujejo: - zdravila proti depresiji kot so moklobemid, amitriptilin, desipramin, maprotilin, venlafaksin in paroksetin - rimiterol in izoprenalin, ki se uporabljata za zdravljenje bolezni dihal - adrenalin, ki se uporablja za hude alergijske reakcije - noradrenalin, dopamin in dobutamin, ki se uporabljajo za zdravljenje bolezni srca in nizkega krvnega tlaka - alfa-metildopo, ki se uporablja za zdravljenje visokega krvnega tlaka - apomorfin, ki se uporablja za zdravljenje Parkinsonove bolezni
Label 10 tablets 30 tablets 100 tablets 130 tablets 175 tablets 250 tablets
Nalepka 10 tablet 30 tablet 100 tablet 130 tablet 175 tablet 250 tablet
However, a longer dosing interval of Levodopa/Carbidopa/Entacapone Orion may be considered for patients who are receiving dialysis therapy (see section 4.2).
Vseeno pa priporočajo, da bi pri bolnikih, ki se zdravijo z dializo, pri odmerjanju zdravila Levodopa/Carbidopa/Entacapone Orion upoštevali daljši interval (glejte poglavje 4.2).
75 mg/18.75 mg/200 mg Light brownish red, oval film-coated tablets marked with ‘LCE 75' on one side.
75 mg/18,75 mg/200 mg Svetlorjavkasto rdeče ovalne filmsko obložene tablete z oznako »LCE 75« na eni strani.
75 mg/18.75 mg/200 mg Each tablet contains 75 mg of levodopa, 18.75 mg of carbidopa and 200 mg of entacapone.
75 mg/18,75 mg/200 mg Ena tableta vsebuje 75 mg levodope, 18,75 mg karbidope in 200 mg entakapona.
175 mg/43.75 mg/200 mg Each tablet contains 175 mg of levodopa, 43.75 mg of carbidopa and 200 mg of entacapone.
175 mg/43,75 mg/200 mg Ena tableta vsebuje 175 mg levodope, 43,75 mg karbidope in 200 mg entakapona.
- The other ingredients in the tablet core are croscarmellose sodium, magnesium stearate, maize starch, mannitol (E421) and povidone (E1201) - The ingredients in the film-coating are glycerol (85 per cent) (E422), hypromellose, magnesium stearate, polysorbate 80, red iron oxide (E172), sucrose, titanium dioxide (E171), and yellow iron oxide (E172).
- Druge sestavine v jedru tablete so: natrijev karmelozat, premreženi (E468), magnezijev stearat, koruzni škrob, manitol (E421) in povidon (E1201) - Sestavine v filmski oblogi so: glicerol (85 odstotkov) (E422), hipromeloza (E464), magnezijev stearat, polisorbat 80 (E433), rdeči železov oksid (E172), saharoza in titanov dioksid (E171).
125 mg/31.25 mg/200 mg Each tablet contains 125 mg of levodopa, 31.25 mg of carbidopa and 200 mg of entacapone.
125 mg/31,25 mg/200 mg Ena tableta vsebuje 125 mg levodope, 31,25 mg karbidope in 200 mg entakapona.
175 mg/43.75 mg/200 mg Light brownish red, oval, unscored film-coated tablets marked with ‘LCE 175' on one side.
175 mg/43,75 mg/200 mg Svetlorjavkasto rdeče ovalne filmsko obložene tablete brez zareze z oznako »LCE 175« na eni strani.
If you stop taking Levodopa/Carbidopa/Entacapone Orion
Če ste prenehali jemati zdravilo Levodopa/Carbidopa/Entacapone Orion
Levodopa/Carbidopa/Entacapone Orion may be taken with or without food.
Zdravilo Levodopa/Carbidopa/Entacapone Orion lahko jemljete med jedjo ali na tešče.
Excipient with known effect: Each tablet contains 1.89 mg of sucrose.
Pomožna snov z znanim učinkom: Ena tableta vsebuje 1,89 mg saharoze.
Neither NMS nor rhabdomyolysis have been reported in association with entacapone treatment from controlled trials in which entacapone was discontinued abruptly.
V kontroliranih raziskavah z nenadno ukinitvijo entakapona ne poročajo o pojavu bodisi NMS bodisi rabdomiolize v povezavi z entakaponskim zdravljenjem.
Brownish or greyish red, round, convex, unscored film-coated tablets marked with ‘LCE 50' on one side.
Rjavkaste ali sivkasto-rdeče okrogle konveksne filmsko obložene tablete brez zareze z oznako »LCE 50« na eni strani.
Each film-coated tablet contains 75 mg of levodopa, 18.75 mg of carbidopa and 200 mg of entacapone.
Ena filmsko obložena tableta vsebuje 75 mg levodope, 18,75 mg karbidope in 200 mg entakapona.
You should not breast-feed during treatment with Levodopa/Carbidopa/Entacapone Orion.
Med zdravljenjem z zdravilom Levodopa/Carbidopa/Entacapone Orion ne smete dojiti.
Levodopa/Carbidopa/Entacapone Orion 75 mg/18.75 mg/200 mg: light brownish red, oval film-coated tablets marked with ‘LCE 75' on one side.
Zdravilo Levodopa/Carbidopa/Entacapone Orion 75 mg/18,75 mg/200 mg: svetlorjavkasto rdeče, ovalne filmsko obložene tablete z oznako »LCE 75« na eni strani.
Film-coating of 75/18.75/200 mg, 125/31.25/200 mg, 175/43.75/200 mg and 200/50/200 mg: Glycerol (85 per cent) (E422)
Filmska obloga pri 75/18,75/200 mg, 125/31,25/200 mg, 175/43,75/200 mg in 200/50/200 mg: glicerol (85 odstotkov) (E422) hipromeloza (E464) magnezijev stearat polisorbat 80 (E433) rdeči železov oksid (E172) saharoza titanov dioksid (E171)
- The ingredients in the film-coating are glycerol (85 per cent) (E422), hypromellose, magnesium stearate, polysorbate 80, red iron oxide (E172), sucrose and titanium dioxide (E171).
- Sestavine v filmski oblogi so: glicerol (85 odstotkov) (E422), hipromeloza (E464), magnezijev stearat, polisorbat 80 (E433), rdeči železov oksid (E172), saharoza in titanov dioksid (E171).
- Each Levodopa/Carbidopa/Entacapone Orion 75 mg/18.75 mg/200 mg tablet contains 75 mg of levodopa, 18.75 mg of carbidopa and 200 mg of entacapone.
- Ena tableta zdravila Levodopa/Carbidopa/Entacapone Orion 75 mg/18,75 mg/200 mg vsebuje 75 mg levodope, 18,75 mg karbidope in 200 mg entakapona.
- are allergic to levodopa, carbidopa or entacapone, or any of the other ingredients of this medicine (listed in section 6) - have narrow-angle glaucoma (an eye disorder) - have a tumour of the adrenal gland - are taking certain medicines for treating depression (combinations of selective MAO-A and
(navedeno v poglavju 6); - če imate angularni glavkom (bolezen oči); - če imate tumor nadledvične žleze; - če jemljete določena zdravila za zdravljenje depresije (kombinacije selektivnih zaviralcev
- The ingredients in the film-coating are glycerol (85 per cent) (E422), hypromellose, magnesium stearate, polysorbate 80, red iron oxide (E172), sucrose, titanium dioxide (E171), and yellow iron oxide (E172).
- Sestavine v filmski oblogi so: glicerol (85 odstotkov) (E422), hipromeloza (E464), magnezijev stearat, polisorbat 80 (E433), rdeči železov oksid (E172), saharoza, titanov dioksid (E171) in rumeni železov oksid (E172).
What Levodopa/Carbidopa/Entacapone Orion looks like and contents of the pack
Izgled zdravila Levodopa/Carbidopa/Entacapone Orion in vsebina pakiranja
150 mg/37.5 mg/200 mg Each tablet contains 150 mg of levodopa, 37.5 mg of carbidopa and 200 mg of entacapone.
150 mg/37,5 mg/200 mg Ena tableta vsebuje 150 mg levodope, 37,5 mg karbidope in 200 mg entakapona.
- The other ingredients in the tablet core are croscarmellose sodium, magnesium stearate, maize starch, mannitol (E421) and povidone (E1201).
- Druge sestavine v jedru tablete so: natrijev karmelozat, premreženi (E468) magnezijev stearat, koruzni škrob, manitol (E421) in povidon (E1201).
Levodopa/Carbidopa/Entacapone Orion 125 mg/31.25 mg/200 mg: light brownish red, oval filmcoated tablets marked with ‘LCE 125' on one side.
Zdravilo Levodopa/Carbidopa/Entacapone Orion 125 mg/31,25 mg/200 mg: svetlorjavkasto rdeče, ovalne tablete z oznako »LCE 125« na eni strani.
2D barcode carrying the unique identifier included [carton only]
Vsebuje dvodimenzionalno črtno kodo z edinstveno oznako.
If you forget to take Levodopa/Carbidopa/Entacapone Orion
Če ste pozabili vzeti zdravilo Levodopa/Carbidopa/Entacapone Orion
levodopa/carbidopa/entacapone orion 75/18.75/200 mg [carton only]
levodopa/carbidopa/entacapone orion 75/18,75/200 mg. [samo škatla]
Talk to your doctor or pharmacist if you think the effect of Levodopa/Carbidopa/Entacapone Orion is too strong or too weak, or if you experience possible side effects.
Če menite, da je učinek zdravila Levodopa/Carbidopa/Entacapone Orion premočan ali prešibak, ali če doživite možne neželene učinke, se posvetujte s svojim zdravnikom ali farmacevtom.
100 mg/25 mg/200 mg Each tablet contains 100 mg of levodopa, 25 mg of carbidopa and 200 mg of entacapone.
100 mg/25 mg/200 mg Ena tableta vsebuje 100 mg levodope, 25 mg karbidope in 200 mg entakapona.
Each film-coated tablet contains 175 mg of levodopa, 43.75 mg of carbidopa and 200 mg of entacapone.
Ena filmsko obložena tableta vsebuje 175 mg levodope, 43,75 mg karbidope in 200 mg entakapona.
Thus, a control of INR is recommended when Levodopa/Carbidopa/Entacapone Orion is initiated for patients receiving warfarin.
Zato je pri bolnikih, ki prejemajo varfarin ob uvedbi zdravila Levodopa/Carbidopa/Entacapone Orion priporočljivo nadzorovati vrednost INR.
50 mg/12.5 mg/200 mg Each tablet contains 50 mg of levodopa, 12.5 mg of carbidopa and 200 mg of entacapone.
50 mg/12,5 mg/200 mg Ena tableta vsebuje 50 mg levodope, 12,5 mg karbidope in 200 mg entakapona.
Blurred vision
zamegljen vid
levodopa/carbidopa/entacapone orion 175/43.75/200 mg [carton only]
levodopa/carbidopa/entacapone orion 175/43,75/200 mg [samo škatla]
No adverse reactions on fertility were observed in preclinical studies with entacapone, carbidopa or levodopa alone.
V predkliničnih študijah s samo entakaponom, karbidopo ali levodopo niso opazili neželenih učinkov na plodnost.
200 mg/50 mg/200 mg Dark brownish red, oval, unscored film-coated tablets marked with ‘LCE 200' on one side.
200 mg/50 mg/200 mg Temnorjavkasto rdeče ovalne filmsko obložene tablete brez zareze z oznako »LCE 200« na eni strani.
The effects of Levodopa/Carbidopa/Entacapone Orion may be weakened by certain medicines.
Nekatera zdravila lahko oslabijo učinek zdravila Levodopa/Carbidopa/Entacapone Orion.
- Each Levodopa/Carbidopa/Entacapone Orion 125 mg/31.25 mg/200 mg tablet contains 125 mg of levodopa, 31.25 mg of carbidopa and 200 mg of entacapone.
- Ena tableta zdravila Levodopa/Carbidopa/Entacapone Orion 125 mg/31,25 mg/200 mg vsebuje 125 mg levodope, 31,25 mg karbidope in 200 mg entakapona.
levodopa/carbidopa/entacapone orion 125/31.25/200 mg [carton only]
levodopa/carbidopa/entacapone orion 125/31,25/200 mg [samo škatla]
- Each Levodopa/Carbidopa/Entacapone Orion 100 mg/25 mg/200 mg tablet contains 100 mg of levodopa, 25 mg of carbidopa and 200 mg of entacapone.
- Ena tableta zdravila Levodopa/Carbidopa/Entacapone Orion 100 mg/25 mg/200 mg vsebuje 100 mg levodope, 25 mg karbidope in 200 mg entakapona.
200 mg/50 mg/200 mg Each tablet contains 200 mg of levodopa, 50 mg of carbidopa and 200 mg of entacapone.
200 mg/50 mg/200 mg Ena tableta vsebuje 200 mg levodope, 50 mg karbidope in 200 mg entakapona.
Levodopa/Carbidopa/Entacapone Orion 175 mg/43.75 mg/200 mg: light brownish red, oval, unscored film-coated tablets marked with ‘LCE 175' on one side.
Zdravilo Levodopa/Carbidopa/Entacapone Orion 175 mg/43,75 mg/200 mg: svetlorjavkasto rdeče, ovalne tablete z oznako »LCE 175« na eni strani.
Each film-coated tablet contains 125 mg of levodopa, 31.25 mg of carbidopa and 200 mg of entacapone.
Ena filmsko obložena tableta vsebuje 125 mg levodope, 31,25 mg karbidope in 200 mg entakapona.
Excipient with known effect: Each tablet contains 2.3 mg of sucrose.
Pomožna snov z znanim učinkom: Ena tableta vsebuje 2,3 mg saharoze.
Levodopa/Carbidopa/Entacapone Orion 75 mg/18.75 mg/200 mg tablet comes in five different pack sizes (10, 30, 100, 130 or 175 tablets).
Zdravilo Levodopa/Carbidopa/Entacapone Orion 75 mg/18,75 mg/200 mg je na razpolago v petih različnih velikostih pakiranja (10, 30, 100, 130 ali 175 tablet).
Levodopa/Carbidopa/Entacapone Orion 150 mg/37.5 mg/200 mg: brownish or greyish red, elongatedellipse shaped, unscored film-coated tablets marked with ‘LCE 150' on one side.
Zdravilo Levodopa/Carbidopa/Entacapone Orion 150 mg/37,5 mg/200 mg so rjavkaste ali sivkastordeče, podolgovate filmsko obložene tablete v obliki elipse brez zareze, z oznako »LCE 150« na eni strani.
Levodopa/Carbidopa/Entacapone Orion 125 mg/31.25 mg/200 mg tablet comes in five different pack sizes (10, 30, 100, 130 or 175 tablets).
Zdravilo Levodopa/Carbidopa/Entacapone Orion 125 mg/31,25 mg/200 mg tablete je na razpolago v petih različnih velikostih pakiranja (10, 30, 100, 130 ali 175 tablet).
levodopa/carbidopa/entacapone orion 150/37.5/200 mg [carton only]
levodopa/carbidopa/entacapone orion 150/37,5/200 mg [samo škatla]
levodopa/carbidopa/entacapone orion 50/12.5/200 mg [carton only]
levodopa/carbidopa/entacapone orion 50/12,5/200 mg [samo škatla]
- Each Levodopa/Carbidopa/Entacapone Orion 50 mg/12.5 mg/200 mg tablet contains 50 mg of levodopa, 12.5 mg of carbidopa and 200 mg of entacapone.
- Ena tableta zdravila Levodopa/Carbidopa/Entacapone Orion 50 mg/12,5 mg/200 mg vsebuje 50 mg levodope, 12,5 mg karbidope in 200 mg entakapona.
Each film-coated tablet contains 50 mg of levodopa, 12.5 mg of carbidopa and 200 mg of entacapone.
Ena filmsko obložena tableta vsebuje 50 mg levodope, 12,5 mg karbidope in 200 mg entakapona.
Excipient with known effect: Each tablet contains 1.9 mg of sucrose.
Pomožna snov z znanim učinkom: Ena tableta vsebuje 1,9 mg saharoze.
levodopa/carbidopa/entacapone orion 100/25/200 mg [carton only]
levodopa/carbidopa/entacapone orion 100/25/200 mg [samo škatla]
Each film-coated tablet contains 100 mg of levodopa, 25 mg of carbidopa and 200 mg of entacapone.
Ena filmsko obložena tableta vsebuje 100 mg levodope, 25 mg karbidope in 200 mg entakapona.
Levodopa/Carbidopa/Entacapone Orion 175 mg/43.75 mg/200 mg tablet comes in five different pack sizes (10, 30, 100, 130 or 175 tablets).
Zdravilo Levodopa/Carbidopa/Entacapone Orion 175 mg/43,75 mg/200 mg tablete je na razpolago v petih različnih velikostih pakiranja (10, 30, 100, 130 ali 175 tablet).
How to take Levodopa/Carbidopa/Entacapone Orion
Kako jemati zdravilo Levodopa/Carbidopa/Entacapone Orion
Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg: dark brownish red, oval, unscored film-coated tablets marked with ‘LCE 200' on one side.
Zdravilo Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg: temnorjavkasto rdeče ovalne filmsko obložene tablete brez zareze z oznako „LCE 200“ na eni strani.
Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg tablet comes in five different pack sizes (10, 30, 100, 130 or 175 tablets).
Zdravilo Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg so na voljo v petih različnih velikostih pakiranja (10, 30, 100, 130 ali 175 tablet).
- Each Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg tablet contains 200 mg of levodopa, 50 mg of carbidopa and 200 mg of entacapone.
- Ena tableta zdravila Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg vsebuje 200 mg levodope, 50 mg karbidope in 200 mg entakapona.
The acute symptoms and signs in these cases of overdose included agitation, confusional state, coma, bradycardia, ventricular tachycardia, Cheyne-Stokes respiration, discolourations of skin, tongue and conjunctiva, and chromaturia.
Podatki v obdobju trženja vključujejo posamične primere prevelikega odmerjanja s poročanim najvišjim dnevnim odmerkom levodope in entakapona najmanj 10.000 mg oz. 40.000 mg. Akutni simptomi in znaki teh primerov prevelikega odmerjanja zajemajo nemir, zmedenost, komo, bradikardijo, ventrikularno tahikardijo, obliko dihanja Cheyne-Stokes, obarvanje kože, jezika, očesne veznice in kromaturija.
Each film-coated tablet contains 150 mg of levodopa, 37.5 mg of carbidopa and 200 mg of entacapone.
Ena filmsko obložena tableta vsebuje 150 mg levodope, 37,5 mg karbidope in 200 mg entakapona.
- Each Levodopa/Carbidopa/Entacapone Orion 150 mg/37.5 mg/200 mg tablet contains 150 mg of levodopa, 37.5 mg of carbidopa and 200 mg of entacapone.
- Ena tableta zdravila Levodopa/Carbidopa/Entacapone Orion 150 mg/37,5 mg/200 mg vsebuje 150 mg levodope, 37,5 mg karbidope in 200 mg entakapona.
levodopa/carbidopa/entacapone orion 200/50/200 mg [carton only]
levodopa/carbidopa/entacapone orion 200/50/200 mg [samo škatla]
Levodopa/Carbidopa/Entacapone Orion contains sucrose (1.89 mg/tablet).
Zdravilo Levodopa/Carbidopa/Entacapone Orion vsebuje saharozo (1,89 mg/tableto).
Each film-coated tablet contains 200 mg of levodopa, 50 mg of carbidopa and 200 mg of entacapone.
Ena filmsko obložena tableta vsebuje 200 mg levodope, 50 mg karbidope in 200 mg entakapona.
Levodopa/Carbidopa/Entacapone Orion 50 mg/12.5 mg/200 mg: brownish or greyish red, round, convex unscored film-coated tablets marked with ‘LCE 50' on one side.
Zdravilo Levodopa/Carbidopa/Entacapone Orion 50 mg/12,5 mg/200 mg so rjavkaste ali sivkastordeče, okrogle, konveksne filmsko obložene tablete brez zareze, z oznako »LCE 50« na eni strani.
Levodopa/Carbidopa/Entacapone Orion contains sucrose
Zdravilo Levodopa/Carbidopa/Entacapone Orion vsebuje saharozo
While the experience with total daily dose greater than 200 mg carbidopa is limited, the maximum recommended daily dose of entacapone is 2,000 mg and therefore the maximum dose is 10 tablets per day for the Levodopa/Carbidopa/Entacapone Orion strengths of 50 mg/12.5 mg/200 mg, 75 mg/18.75 mg/200 mg, 100 mg/25 mg/200 mg, 125 mg/31.25 mg/200 mg and 150 mg/37.5 mg/200 mg.
To pomeni, da znaša maksimalni odmerek 10 tablet na dan zdravila Levodopa/Carbidopa/Entacapone Orion jakosti 50 mg/12,5 mg/200 mg, 75 mg/18,75 mg/200 mg, 100 mg/25 mg/200 mg, 125 mg/31,25 mg/200 mg in 150 mg/37,5 mg/200 mg.
Excipient with known effect: Each tablet contains 1.6 mg of sucrose.
Pomožna snov z znanim učinkom: Ena tableta vsebuje 1,6 mg saharoze.